A new model for
health and life science
innovation.
In partnership with leading private equity firm, GTCR, Corza Health is rewriting the model for building and scaling health and life science companies.
Sourcing and placing exceptional leaders within an organization that builds a winning culture centered on highly effective teamwork
Driving operational efficiencies through the utilization of key performance indicators and other, proprietary methods
Ensuring that appropriate corporate governance, risk management, compliance, and controls are established and properly monitored
Establishing of an M&A function fully supporting buy- and sell-side transactions as well as public exit opportunities
Providing growth capital to execute transformational investments
Championing innovation to translate customer needs into best-in-class technology solutions that delight
Our leadership team is driving innovation.
We are committed to changing the healthcare system through investing in like-minded companies driving better financial, operational and clinical outcomes.
Focusing on leading organizations with dynamic management teams, Corza Health provides governance, strategic insights and growth capital to expand equity value. Our differentiated capabilities are supported by a shared mindset grounded in transparency, honesty and integrity with our partners.
Corza Health makes investments in healthcare companies to help accelerate growth. We invest into high-caliber teams and provide the appropriate relationships, learnings and support to create industry-leading brands, products and services.
Greg Lucier founded Corza Health in partnership with leading private equity firm GTCR to combine his 30+ years of life sciences leadership with GTCR’s unrivaled track record of creating unique, value-generating private equity opportunities.
Greg most recently served as Chairman and CEO at NuVasive, a global technology leader in minimally invasive spine and orthopedic surgery. Prior to that, he was Chairman and CEO at Life Technologies—formerly Invitrogen—which he grew into a global life sciences powerhouse that was acquired by Thermo Fisher Scientific for more than $15 billion. He spent the first part of his career with the General Electric—including GE Healthcare—in a variety of corporate officer and executive roles.
Greg serves on several public and private company boards, including Antylia Scientific, Catalent, Dentsply Sirona, Maravai LifeSciences, and Pleno, Inc. He has been actively involved in a variety of community and civic engagements, including serving as the Chairperson for Sanford Burnham Research Institute in La Jolla, California and the Smithsonian Natural History Museum.
He holds a Bachelor’s in Industrial Engineering from Pennsylvania State University and a Master’s in Business Administration from Harvard Business School.
In his free time, Greg enjoys riding motorcycles—both on and off-road—as well as skiing. His family are proud supporters of the Lucier Fund for Engineering Equity at Penn State.
Dennis Crowley brings nearly thirty years of experience in strategy and business development, driving organic and acquired growth through mergers and acquisitions, joint ventures, and strategic affiliations.
Dennis most recently served as SVP, Business Development & Licensing at Baxter Healthcare, a leader in treating kidney disease and other chronic and acute medical conditions. Dennis has also held executive leadership roles at Tyco International and Medtronic/Covidien, among others. He holds a Bachelor’s degree from Harvard College.
We partnered with the leading private equity firm.
Our key partner in this endeavor is leading private equity firm GTCR, pioneer of The Leaders Strategy™. Representing an important complement to Corza Health leadership’s own expertise and extensive network of experienced and established leaders in their domains, Leaders Strategy™ teams offer accretive industry insights, informational advantages, and a talent pool which can be leveraged in support of our portfolio companies.